ATLASCitius Oncology (CTOR) earnings date: Dec 22, 2026
Citius Oncology (CTOR) reports earnings for the quarter ended Sep 30, 2026 on Tue, Dec 22, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CTOR
| Last price | $0.66 (+19.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.6% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Citius Oncology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Citius Oncology reports on Dec 22, 2026. One email the day before, with ATLAS’s read on Citius Oncology. You can switch it off at any time.
Alert me before CTOR reportsFree to start. Creating an account takes under a minute.
Notify me when Citius Oncology reports
Track CTOR free Add Citius Oncology to a free ATLAS watchlist and see its next report date in one place.
CTOR earnings at a glance
| Next report (confirmed) | Tue, Dec 22, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 14, 2026 · Miss |
| Beat rate (last 5 reports) | 1 of 5 (20%) |
| Average EPS surprise | -528.3% |
| Average move around a report | ±8.2% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Citius Oncology earnings history: last 5 reports
Citius Oncology last reported on Aug 14, 2026: EPS of -$0.08 against an estimate of -$0.07 (-14.3% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.07 | -$0.08 | -14.3% | Miss | -10.5% |
| Jul 29, 2026 | $2.29 | $2.81 | +22.7% | Beat | +6.1% |
| May 15, 2026 | -$0.01 | -$0.27 | -2,600.0% | Miss | -15.8% |
| Feb 13, 2026 | -$0.04 | -$0.06 | -50.0% | Miss | 0.0% |
| Dec 23, 2025 | -$0.06 | -$0.06 | 0.0% | In line | -8.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CTOR
See the fair value, the probability range and the earnings history of Citius Oncology on its ATLAS page.
Citius Oncology (CTOR) stock analysisPlans from €3.99 a month.
Citius Oncology earnings: frequently asked questions
When does Citius Oncology (CTOR) report earnings?
Citius Oncology is scheduled to report on Tuesday, December 22, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does CTOR beat earnings estimates?
Of its last 5 reports with a recorded result, Citius Oncology beat the EPS estimate 1 times; the average surprise was -528.3%. Past results do not predict the next one.
How much does CTOR move around earnings?
Over its last 5 reports the stock moved an average of 8.2% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Citius Oncology beat earnings estimates last quarter?
Citius Oncology last reported on Aug 14, 2026: EPS of -$0.08 against an estimate of -$0.07 (-14.3% surprise), a miss.
How much does CTOR usually move in a day?
On a normal trading day the ATLAS model puts CTOR’s one-day range at about ±5.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Dec 22, 2026
Educational information, not investment advice. Disclaimer